Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Frequently asked questions
What sector does Boryung Pharm (003850) operate in?
Boryung Pharm belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Boryung Pharm (003850) current stock price?
As of the latest data, Boryung Pharm stock price is ₩8,300, with a previous close of ₩8,300.
What is Boryung Pharm (003850) current market capitalization?
Boryung Pharm market cap is approximately 678.48 billion.
What is Boryung Pharm (003850) Earnings Per Share (EPS)?
The trailing EPS is ₩1,475, and the forward EPS is ₩795.
What is Boryung Pharm (003850) Price-to-Earnings (P/E) ratio?
Boryung Pharm current P/E ratio is 5.63, with a forward P/E of 10.44.
What is Boryung Pharm (003850) EBITDA?
Boryung Pharm EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 48.37 billion.
Does Boryung Pharm (003850) pay dividends?
Yes. Boryung Pharm pays annual dividends with an annualized yield of 1.93% and an estimated annual payout of ₩160 per share.
When is the next ex-dividend date for Boryung Pharm (003850)?
The next ex-dividend date is scheduled for December 29, 2026.
What is Boryung Pharm (003850) beta (volatility) score?
Boryung Pharm has a beta of 0.335, indicating lower volatility than the overall market.
